Pluri

Pluri

© Pluri
Company News

Pluri Secures $6.5 Million Investment and Acquires Majority Stake in Cell-Based Cacao Producer Kokomodo

Biotechnology firm Pluri Inc., a company specializing in cell-based technology, has announced a $6.5 million private investment led by global investor Alejandro Weinstein. As part of the transaction, Weinstein will join Pluri’s Board of Directors. Concurrently, the company is acquiring a 71% stake in Israeli AgTech firm Kokomodo Ltd., which focuses on cultivated cacao production, for $4.5 million in common shares. The proceeds from the investment will be used to bolster Pluri’s working capital and further its efforts in cell-based technology development. Simultaneously, Pluri will acquire Kokomodo Ltd. by purchasing a 71% stake from Chutzpah Holdings Ltd. and Plantae Ltd., both controlled by Weinstein. The acquisition, valued at $4.5 million, will be settled in 976,139 Pluri common shares. The deal positions Pluri to expand its …

more

Topics:

Pluri announces that it has secured a patent from the Israel Patent Office for its System for its 3D bioreactor plant cells technology.

© Pluri
Company News

Pluri Receives First-Ever Patent for 3D Bioreactor Technology in Plant Cell Cultivation

Pluri (Nasdaq:PLUR) (TASE:PLUR), parent company of the recently launched cell-based coffee biotech PluriAgtech, announces that it has secured a patent from the Israel Patent Office for its “System for 3D Cultivation of Plant Cells and Methods of Use.” Pluri claims this is the first-ever patent approval for 3D bioreactor technology in plant cell cultivation. Pluri’s 3D technology enables the cultivation of plant cells in bioreactors to develop sustainable and disease-free plant material for various sectors, from sustainable agriculture to healthcare.   According to the company,  approximately one-fifth of the 50,000 medical plants used today are on a list of threatened species, while climate change and restricted access to fresh water threaten temperature-sensitive crops such as coffee and cacao. Yaky Yanay, Pluri’s CEO and President, commented: “PluriAgtech’s patented …

more

Pluri develops cell-based coffee at industrial scale

© Pluri
Plant Cell Cultivation

PluriAgtech Introduces Cell-Based Coffee to Provide an Alternative to Traditional Production

Israeli biotechnology firm Pluri, formerly Pluristem, (Nasdaq, TASE: PLUR) has launched PluriAgtech, a subsidiary leveraging plant cell culture to grow sustainable coffee and break away from traditional farming methods.  As global warming continues to impact the coffee industry, shrinking viable land for cultivation and increasing demand leads to higher prices and less production.  According to the company, by 2050, land for coffee production will be reduced by half, and 30% must shift to higher altitudes since Arabica plants are temperature-sensitive. Moreover, the rising demand for coffee significantly impacts the environment, resulting in deforestation and increased water and pesticide use.  PluriAgtech claims it can produce high-quality “real” coffee at scale while reducing water usage by 98% and growing areas by 95%, thus preventing deforestation and making …

more